Governors Lane LP Bristol Myers Squibb CO Call Options Transaction History

Governors Lane LP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $5.35 Million - $5.92 Million	-120,000 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $61.3 Million - $73 Million	-1,357,500 Reduced 91.88%	120,000 $5.73 Million
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $37.3 Million - $46.5 Million	738,800 Added 100.01%	1,477,500 $0
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $44.3 Million - $51 Million	-738,800 Reduced 50.0%	738,700 $46.7 Million
Q4 2017 Feb 08, 2018	BUY	$59.94 - $65.35 $7.04 Million - $7.68 Million	117,500 Added 8.64%	1,477,500 $90.5 Million
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $75.1 Million - $86.7 Million	1,360,000	1,360,000 $86.7 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Governors Lane LP, based on Form 13F filings with the SEC.

Stay updated on Governors Lane LP with notifications on news.